Guth Ethan, Farris Mindy, Bovee Michael, Francklyn Christopher S
Department of Biochemistry, College of Medicine, Health Sciences Complex, University of Vermont, Burlington, Vermont 05405, USA.
J Biol Chem. 2009 Jul 31;284(31):20753-62. doi: 10.1074/jbc.M109.021311. Epub 2009 Jun 1.
Aminoacyl-tRNA synthetases (ARSs) join amino acids to their cognate tRNAs to initiate protein synthesis. Class II ARS possess a unique catalytic domain fold, possess active site signature sequences, and are dimers or tetramers. The dimeric class I enzymes, notably TyrRS, exhibit half-of-sites reactivity, but its mechanistic basis is unclear. In class II histidyl-tRNA synthetase (HisRS), amino acid activation occurs at different rates in the two active sites when tRNA is absent, but half-of-sites reactivity has not been observed. To investigate the mechanistic basis of the asymmetry, and explore the relationship between adenylate formation and conformational events in HisRS, a fluorescently labeled version of the enzyme was developed by conjugating 7-diethylamino-3-((((2-maleimidyl)ethyl)amino)carbonyl)coumarin (MDCC) to a cysteine introduced at residue 212, located in the insertion domain. The binding of the substrates histidine, ATP, and 5'-O-[N-(l-histidyl)sulfamoyl]adenosine to MDCC-HisRS produced fluorescence quenches on the order of 6-15%, allowing equilibrium dissociation constants to be measured. The rates of adenylate formation measured by rapid quench and domain closure as measured by stopped-flow fluorescence were similar and asymmetric with respect to the two active sites of the dimer, indicating that conformational change may be rate-limiting for product formation. Fluorescence resonance energy transfer experiments employing differential labeling of the two monomers in the dimer suggested that rigid body rotation of the insertion domain accompanies adenylate formation. The results support an alternating site model for catalysis in HisRS that may prove to be common to other class II aminoacyl-tRNA synthetases.
氨酰-tRNA合成酶(ARSs)将氨基酸与其对应的tRNA连接起来以启动蛋白质合成。II类ARS具有独特的催化结构域折叠,拥有活性位点特征序列,并且是二聚体或四聚体。二聚体I类酶,特别是酪氨酰-tRNA合成酶(TyrRS),表现出半位点反应性,但其机制基础尚不清楚。在II类组氨酰-tRNA合成酶(HisRS)中,当不存在tRNA时,两个活性位点的氨基酸活化速率不同,但尚未观察到半位点反应性。为了研究不对称性的机制基础,并探索HisRS中腺苷酸形成与构象事件之间的关系,通过将7-二乙氨基-3-((((2-马来酰亚胺基)乙基)氨基)羰基)香豆素(MDCC)与位于插入结构域的第212位残基处引入的半胱氨酸偶联,开发了一种该酶的荧光标记版本。底物组氨酸、ATP和5'-O-[N-(l-组氨酰)氨磺酰基]腺苷与MDCC-HisRS的结合产生了约6-15%的荧光猝灭,从而可以测量平衡解离常数。通过快速淬灭测量的腺苷酸形成速率和通过停流荧光测量的结构域闭合速率在二聚体的两个活性位点方面是相似且不对称的,表明构象变化可能是产物形成的限速步骤。使用二聚体中两个单体的差异标记进行的荧光共振能量转移实验表明,插入结构域的刚体旋转伴随着腺苷酸的形成。这些结果支持了HisRS中催化的交替位点模型,该模型可能被证明是其他II类氨酰-tRNA合成酶所共有的。